骨科医生主导的骨质疏松(OSLO)照护模式降低骨质疏松性骨折患者的早期再骨折率并改善治疗依从性
本研究为单中心回顾性比较队列研究,纳入2008至2018年筛查并治疗的2855例患者,比较骨科医生主导的骨质疏松照护模式(OSLO-MoC)与个案管理者主导模式(CMLO-MoC)。OSLO-MoC实施与更高的患者招募率(OR 1.26)、12个月药物依从性改善(OR 2.61)及12个月继发骨折风险降低(OR 0.14)相关。
要点
- OSLO-MoC实施与12个月继发骨折风险降低相关,OR 0.14(95%CI 0.03-0.66,P=0.013)。
- OSLO-MoC实施与12个月药物依从性改善相关,OR 2.61(95%CI 2.03-3.36,P<0.001)。
- OSLO-MoC实施与更高患者招募相关,OR 1.26(95%CI 1.06-1.49,P=0.007)。
核心结论
- OSLO-MoC在降低再骨折率及改善骨质疏松药物启动和依从性方面显示有效。
研究设计与样本
- 单中心、回顾性、比较队列研究,纳入2008至2018年在一家骨科手术单元筛查并治疗的所有继发性骨质疏松骨折预防患者;2008至2013年患者纳入CMLO-MoC,2014至2018年纳入OSLO-MoC。
- 共筛查7388例患者,其中2855例符合分析条件;CMLO-MoC组招募1234例,OSLO-MoC组招募1621例。
- 采用逻辑回归分析识别OSLO-MoC实施、性别、种族、婚姻状况和教育水平等对患者招募、治疗依从性及12个月随访继发骨折率的显著预测因素。
- 证据等级为IV级。
主要发现
- OSLO-MoC实施与更高的患者招募相关,OR 1.26(95%CI 1.06-1.49,P=0.007)。
- 在2855例招募患者中,OSLO-MoC实施(OR 2.61,95%CI 2.03-3.36,P<0.001)和较高教育水平(OR 1.428,95%CI 1.02-1.43,P=0.037)与12个月药物依从性改善相关。
- OSLO-MoC实施是唯一与12个月继发骨折风险降低相关的因素,OR 0.14(95%CI 0.03-0.66,P=0.013)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This study aims to evaluate the efficacy of an Orthopaedic Surgeon Led Osteoporosis Model of Care (OSLO-MoC) in improving care of patients with primary osteoporotic fractures. The OSLO-MOC has shown to be effective in improving osteoporotic medication initiation and compliance and reducing secondary fracture rates in patients. PURPOSE: This study aims to evaluate the efficacy of an Orthopaedic Surgeon Led Osteoporosis Model of Care (OSLO-MoC) as compared to a Case Manager Led Osteoporosis Model of Care (CMLO-MoC) in reducing early osteoporotic re-fracture rates and treatment compliance in patients. METHODS: This was a single centre, retrospective, comparative cohort study of all patients screened and treated for secondary osteoporotic fracture prevention from the 2008 to 2018 at an orthopaedic surgical unit. From the 2008 to 2013, patients were recruited under the CMLO-MoC and from 2014 to 2018, under the OSLO-MOC. Logistics regression analysis was used to identify significant predictors such as OSLO-MOC implementation, gender, ethnicity, marital status and education level for patient recruitment, treatment compliance and secondary fracture rates at 12-month follow-up. RESULTS: Over a 10-year period, 7388 patients were screened of which 2855 patients were eligible for analysis. A total of 1234 patients were recruited under CMLO-MoC and 1621 patients under OSLO-MOC. Implementation of the OSLO-MOC was associated with greater patient recruitment, OR 1.26 (95%CI 1.06-1.49, P = 0.007). Of the 2855 patients recruited, OSLO-MOC implementation, OR 2.61 (95%CI 2.03-3.36, P < 0.001), and a higher level of education, OR 1.428 (95%CI 1.02-1.43, P = 0.037), were associated with improved compliance to medication at 12 months. OSLO-MOC implementation was the only factor associated with reduced risk of secondary fractures at 12 months, OR 0.14 (95%CI 0.03-0.66, P = 0.013). CONCLUSION: The OSLO-MOC has shown to be effective in reducing the rate of re-fracture and osteoporotic medication initiation and compliance of patients. LEVEL OF EVIDENCE: IV.
引用
- Ding BTK, Lim HF, Johari F, et al. An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures. Osteoporos Int. 2022. PMID: 36409358. doi:10.1007/s00198-022-06595-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。